Clinical Trials Directory

Trials / Completed

CompletedNCT05721131

NC Thermometer (Gen 3) ISO 80601-2-56 Validation

Status
Completed
Phase
Study type
Observational
Enrollment
105 (actual)
Sponsor
Natural Cycles · Industry
Sex
All
Age
5 Years
Healthy volunteers

Summary

The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

Detailed description

The purpose of this clinical study is to validate the clinical accuracy of the NC° Thermometer (Gen 3) according to the requirements of ISO 80601-2-56:2017. The NC° Thermometer (Gen 3) (the device under study (DUT)) is a predictive thermometer that operates in adjusted mode. The Welch Allyn oral thermometer (Welch Allyn Spot Vital Signs 420 SureTemp temperature module, Welch Allyn, San Diego, CA) with a measurement accuracy of ± 0.1 °C in monitor mode will be used the reference clinical thermometer (RCT). During the clinical study, subjects will be asked to perform three consecutive oral measurements with the DUT, and one oral measurement with the RCT.

Conditions

Interventions

TypeNameDescription
DEVICENC° Thermometer (Gen 3)The NC° Thermometer (Gen3) is used orally for the intermittent measurement and monitoring of human body temperature. The device can be used by adults and children over the age of 5 years old.

Timeline

Start date
2023-01-10
Primary completion
2023-04-27
Completion
2023-04-27
First posted
2023-02-09
Last updated
2023-10-30

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05721131. Inclusion in this directory is not an endorsement.